SIRT1 and colorectal carcinoma: In contrast, treatment with Sirt1-ASO clearly up-regulated levels of specific CSC biomarkers in a dose-dependent manner, highlighting the essential role for Sirt1 in resveratrol-promoting anti-tumorigenic effects in CRC cells.